Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study
Identifieur interne : 000148 ( France/Analysis ); précédent : 000147; suivant : 000149Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study
Auteurs : Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-02-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Anxiety, Anxiety Disorders (epidemiology), Anxiety Disorders (etiology), Anxiety disorder, Beck Anxiety Inventory (BAI), Cross sectional study, Cross-Sectional Studies, Depression, Evaluation scale, Female, Hamilton Anxiety Rating Scale (HARS), Humans, International Cooperation, Inventory, Male, Middle Aged, Nervous system diseases, Odds Ratio, Parkinson Disease (complications), Parkinson Disease (epidemiology), Parkinson disease, Parkinson's disease, Prevalence, Psychiatric Status Rating Scales, Severity of Illness Index, Statistics, Nonparametric, Symptomatology, anxiety, depression.
- MESH :
- complications : Parkinson Disease.
- epidemiology : Anxiety Disorders, Parkinson Disease.
- etiology : Anxiety Disorders.
- Aged, Cross-Sectional Studies, Female, Humans, International Cooperation, Male, Middle Aged, Odds Ratio, Prevalence, Psychiatric Status Rating Scales, Severity of Illness Index, Statistics, Nonparametric.
Abstract
Anxiety is understudied in Parkinson's disease (PD), which is not justified by the prevalence and impact of anxiety disorders on quality of life in PD patients. In this cross‐sectional study, 342 patients suffering from idiopathic PD underwent a research‐based assessment including DSM IV criteria for anxiety disorders, the Hamilton anxiety rating scale (HARS) and the beck anxiety inventory (BAI). Thirty‐four percent (34%) of subjects met the DSM IV criteria for at least one anxiety disorder; 11.8% met criteria for multiple anxiety disorders; and 11.4% had clinically relevant anxiety symptoms without meeting the criteria for any specific anxiety disorder. Score profiles on the HARS and BAI differed significantly between the disorders, but these differences were associated with different scores on a limited number of items, and the respective symptom profiles were not readily interpretable. Female sex, the presence of motor fluctuations, as well as a previous history of an anxiety disorder were markers for anxiety disorders. The use of a mono‐amino oxidase (MAO)‐B inhibitor was associated with a reduced prevalence of anxiety disorders. Research into anxiety in PD is hampered by the questionable validity of DSM IV defined anxiety disorders in this population. A first focus for research should therefore be the identification of clinically useful anxiety presentations and their validation in PD. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23528
Affiliations:
- Australie, Espagne, France, Pays-Bas, États-Unis
- Communauté de Madrid, Maryland
- Baltimore, Lille, Madrid
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000448
- to stream Istex, to step Curation: 000448
- to stream Istex, to step Checkpoint: 000096
- to stream PubMed, to step Corpus: 001450
- to stream PubMed, to step Curation: 001450
- to stream PubMed, to step Checkpoint: 001076
- to stream Ncbi, to step Merge: 002F70
- to stream Ncbi, to step Curation: 002F70
- to stream Ncbi, to step Checkpoint: 002F70
- to stream Main, to step Merge: 001417
- to stream PascalFrancis, to step Corpus: 000673
- to stream PascalFrancis, to step Curation: 002645
- to stream PascalFrancis, to step Checkpoint: 000384
- to stream Main, to step Merge: 001974
- to stream Main, to step Curation: 001364
- to stream Main, to step Exploration: 001364
- to stream France, to step Extraction: 000148
Links to Exploration step
ISTEX:BAC9A14C486FC4DDDE842C685558E2300E5FB8FBLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study</title><author><name sortKey="Leentjens, Albert F G" sort="Leentjens, Albert F G" uniqKey="Leentjens A" first="Albert F. G." last="Leentjens">Albert F. G. Leentjens</name></author><author><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name></author><author><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name></author><author><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name></author><author><name sortKey="Richard, Irene H" sort="Richard, Irene H" uniqKey="Richard I" first="Irene H." last="Richard">Irene H. Richard</name></author><author><name sortKey="Starkstein, Sergio E" sort="Starkstein, Sergio E" uniqKey="Starkstein S" first="Sergio E." last="Starkstein">Sergio E. Starkstein</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BAC9A14C486FC4DDDE842C685558E2300E5FB8FB</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23528</idno><idno type="url">https://api.istex.fr/document/BAC9A14C486FC4DDDE842C685558E2300E5FB8FB/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000448</idno><idno type="wicri:Area/Istex/Curation">000448</idno><idno type="wicri:Area/Istex/Checkpoint">000096</idno><idno type="wicri:doubleKey">0885-3185:2011:Leentjens A:symptomatology:and:markers</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:21312281</idno><idno type="wicri:Area/PubMed/Corpus">001450</idno><idno type="wicri:Area/PubMed/Curation">001450</idno><idno type="wicri:Area/PubMed/Checkpoint">001076</idno><idno type="wicri:Area/Ncbi/Merge">002F70</idno><idno type="wicri:Area/Ncbi/Curation">002F70</idno><idno type="wicri:Area/Ncbi/Checkpoint">002F70</idno><idno type="wicri:Area/Main/Merge">001417</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:11-0211297</idno><idno type="wicri:Area/PascalFrancis/Corpus">000673</idno><idno type="wicri:Area/PascalFrancis/Curation">002645</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000384</idno><idno type="wicri:doubleKey">0885-3185:2011:Leentjens A:symptomatology:and:markers</idno><idno type="wicri:Area/Main/Merge">001974</idno><idno type="wicri:Area/Main/Curation">001364</idno><idno type="wicri:Area/Main/Exploration">001364</idno><idno type="wicri:Area/France/Extraction">000148</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study</title><author><name sortKey="Leentjens, Albert F G" sort="Leentjens, Albert F G" uniqKey="Leentjens A" first="Albert F. G." last="Leentjens">Albert F. G. Leentjens</name><affiliation wicri:level="1"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Psychiatry, Maastricht University Medical Center, Maastricht</wicri:regionArea><wicri:noRegion>Maastricht</wicri:noRegion></affiliation></author><author><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Neurology and Movement Disorders Unit, Lille University Hospital, Lille</wicri:regionArea><placeName><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name><affiliation wicri:level="3"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Psychiatry and Neurology, Johns Hopkins University School of Medicine, Baltimore</wicri:regionArea><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Current Address: Mental Health Care Line, Michael E. DeBakey Veterans Administration Medical Center and Menninger Department of Psychiatry, Baylor College of Medicine, Houston</wicri:regionArea><wicri:noRegion>Houston</wicri:noRegion></affiliation></author><author><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Area of Applied Epidemiology and CIBERNED, National Centre for Epidemiology, Carlos III Institute of Health, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Richard, Irene H" sort="Richard, Irene H" uniqKey="Richard I" first="Irene H." last="Richard">Irene H. Richard</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Neurology and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester</wicri:regionArea><wicri:noRegion>Rochester</wicri:noRegion></affiliation></author><author><name sortKey="Starkstein, Sergio E" sort="Starkstein, Sergio E" uniqKey="Starkstein S" first="Sergio E." last="Starkstein">Sergio E. Starkstein</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>School of Psychiatry, University of Western Australia and Fremantle Hospital, Fremantle</wicri:regionArea><wicri:noRegion>Fremantle</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-02-15">2011-02-15</date><biblScope unit="vol">26</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="484">484</biblScope><biblScope unit="page" to="492">492</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">BAC9A14C486FC4DDDE842C685558E2300E5FB8FB</idno><idno type="DOI">10.1002/mds.23528</idno><idno type="ArticleID">MDS23528</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Anxiety</term><term>Anxiety Disorders (epidemiology)</term><term>Anxiety Disorders (etiology)</term><term>Anxiety disorder</term><term>Beck Anxiety Inventory (BAI)</term><term>Cross sectional study</term><term>Cross-Sectional Studies</term><term>Depression</term><term>Evaluation scale</term><term>Female</term><term>Hamilton Anxiety Rating Scale (HARS)</term><term>Humans</term><term>International Cooperation</term><term>Inventory</term><term>Male</term><term>Middle Aged</term><term>Nervous system diseases</term><term>Odds Ratio</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Prevalence</term><term>Psychiatric Status Rating Scales</term><term>Severity of Illness Index</term><term>Statistics, Nonparametric</term><term>Symptomatology</term><term>anxiety</term><term>depression</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Anxiety Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Anxiety Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>International Cooperation</term><term>Male</term><term>Middle Aged</term><term>Odds Ratio</term><term>Prevalence</term><term>Psychiatric Status Rating Scales</term><term>Severity of Illness Index</term><term>Statistics, Nonparametric</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Angoisse anxiété</term><term>Echelle d'évaluation</term><term>Etat dépressif</term><term>Etude transversale</term><term>Inventaire</term><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term><term>Symptomatologie</term><term>Trouble anxieux</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Anxiety is understudied in Parkinson's disease (PD), which is not justified by the prevalence and impact of anxiety disorders on quality of life in PD patients. In this cross‐sectional study, 342 patients suffering from idiopathic PD underwent a research‐based assessment including DSM IV criteria for anxiety disorders, the Hamilton anxiety rating scale (HARS) and the beck anxiety inventory (BAI). Thirty‐four percent (34%) of subjects met the DSM IV criteria for at least one anxiety disorder; 11.8% met criteria for multiple anxiety disorders; and 11.4% had clinically relevant anxiety symptoms without meeting the criteria for any specific anxiety disorder. Score profiles on the HARS and BAI differed significantly between the disorders, but these differences were associated with different scores on a limited number of items, and the respective symptom profiles were not readily interpretable. Female sex, the presence of motor fluctuations, as well as a previous history of an anxiety disorder were markers for anxiety disorders. The use of a mono‐amino oxidase (MAO)‐B inhibitor was associated with a reduced prevalence of anxiety disorders. Research into anxiety in PD is hampered by the questionable validity of DSM IV defined anxiety disorders in this population. A first focus for research should therefore be the identification of clinically useful anxiety presentations and their validation in PD. © 2011 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Australie</li><li>Espagne</li><li>France</li><li>Pays-Bas</li><li>États-Unis</li></country><region><li>Communauté de Madrid</li><li>Maryland</li></region><settlement><li>Baltimore</li><li>Lille</li><li>Madrid</li></settlement></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Leentjens, Albert F G" sort="Leentjens, Albert F G" uniqKey="Leentjens A" first="Albert F. G." last="Leentjens">Albert F. G. Leentjens</name></noRegion></country><country name="France"><noRegion><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name></noRegion></country><country name="États-Unis"><region name="Maryland"><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name></region><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name><name sortKey="Richard, Irene H" sort="Richard, Irene H" uniqKey="Richard I" first="Irene H." last="Richard">Irene H. Richard</name></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name></region></country><country name="Australie"><noRegion><name sortKey="Starkstein, Sergio E" sort="Starkstein, Sergio E" uniqKey="Starkstein S" first="Sergio E." last="Starkstein">Sergio E. Starkstein</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000148 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000148 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:BAC9A14C486FC4DDDE842C685558E2300E5FB8FB
|texte= Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study
}}
| This area was generated with Dilib version V0.6.23. |  |